Phase out as a treatment for chronic untreatable tinnitus: a double blind crossover trial
- Conditions
- TinnitusEar, Nose and ThroatEar disorders
- Registration Number
- ISRCTN17631678
- Lead Sponsor
- niversity Medical Centre Groningen (UMCG) (The Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
1. Subjects greater than 18 years
2. Unilateral or bilateral tinnitus
3. Predominant tone tinnitus by history
4. Tinnitus for minimum of three months
1. Acoustic neurinoma
2. Aortic/outflow tract stenosis
3. Pulsatile tinnitus
4. Pregnancy
5. Inability to correct use of test equipment: unable to cooperate during audiologic examination
6. Known tinnitus etiology, which would demand other treatment
7. Hearing loss greater than 60 decibel compared with standardised normal hearing on standard frequencies of a tone audiogram (250, 500, 1000, 2000, 4000 and 8000 hertz)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method